Given the unique products OSX have in their portfolio, it is an attractive proposition for a takeover. However, since the company has not been able to make sizeable/ noteworthy inroads into the medical market, a potential buyer may not bid aggressively. Even if OSX gets an offer 50% higher than the current market price, it would be around 48cents per share. At that price, unfortunately most retail investors will not still break even.
At current levels, I am undecided if I want to average out further!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.107M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 998717 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 1005704 | 5 |
View Market Depth
| Last trade - 09.30am 18/07/2025 (20 minute delay) ? |
| OSX (ASX) Chart |
Day chart unavailable